<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459928</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1595</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101595</ELocationID><Abstract><AbstractText>5-Aminolevulinic acid (5-ALA), a non-proteinogenic amino acid, is an intermediate in the biosynthesis of heme and exerts antiviral effects against feline coronavirus (FCoV); however, the underlying mechanisms remain unclear. In the biosynthesis of heme, 5-ALA is condensed and converted to protoporphyrin IX (PpIX), which is then transformed into heme by the insertion of ferrous iron. Previous research has suggested that the metabolites generated during heme biosynthesis contribute to the antiviral effects of 5-ALA. Therefore, the present study investigated the in vitro mechanisms responsible for the antiviral effects of 5-ALA. The results obtained revealed that 5-ALA and PpIX both effectively reduced the viral titer in the supernatant of FCoV-infected fcwf-4 cells. Moreover, PpIX exerted virucidal effects against FCoV. We also confirmed that 5-ALA increased PpIX levels in cells. While hemin induced heme oxygenase-1 gene expression, it did not reduce the viral titer in the supernatant. Sodium ferrous citrate decreased PpIX levels and suppressed the antiviral effects of 5-ALA. Collectively, these results suggest that the antiviral effects of 5-ALA against FCoV are dependent on PpIX.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doki</LastName><ForeName>Tomoyoshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4566-5025</Identifier><AffiliationInfo><Affiliation>Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Junna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokunaga</LastName><ForeName>Misa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>To</LastName><ForeName>Kaito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orino</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takano</LastName><ForeName>Tomomi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3468-0708</Identifier><AffiliationInfo><Affiliation>Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Not applicable</GrantID><Agency>KIYAN PHARMA Co., Ltd. (formerly Neopharma Japan Co., Ltd.)</Agency><Country /></Grant><Grant><GrantID>JSPS KAKENHI Grant Number 24K09251</GrantID><Agency>Japan Society for the Promotion of Science (JSPS)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>88755TAZ87</RegistryNumber><NameOfSubstance UI="D000622">Aminolevulinic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011524">Protoporphyrins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C2K325S808</RegistryNumber><NameOfSubstance UI="C028025">protoporphyrin IX</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>42VZT0U6YR</RegistryNumber><NameOfSubstance UI="D006418">Heme</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.18</RegistryNumber><NameOfSubstance UI="D051547">Heme Oxygenase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000622" MajorTopicYN="Y">Aminolevulinic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011524" MajorTopicYN="Y">Protoporphyrins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016765" MajorTopicYN="Y">Coronavirus, Feline</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006418" MajorTopicYN="Y">Heme</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051547" MajorTopicYN="N">Heme Oxygenase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-aminolevulinic acid</Keyword><Keyword MajorTopicYN="N">feline coronavirus</Keyword><Keyword MajorTopicYN="N">protoporphyrin IX</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459928</ArticleId><ArticleId IdType="pmc">PMC11512371</ArticleId><ArticleId IdType="doi">10.3390/v16101595</ArticleId><ArticleId IdType="pii">v16101595</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taxon Details|ICTV.  [(accessed on 24 July 2024)].  Available online:  https://ictv.global/taxonomy/taxondetails?taxnode_id=202301849&amp;taxon_name=Alphacoronavirus%20suis.</Citation></Reference><Reference><Citation>Tekes G., Thiel H.J. Advances in Virus Research. Volume 96. Academic Press; Cambridge, MA, USA: 2016. Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis; pp. 193–218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112361</ArticleId><ArticleId IdType="pubmed">27712624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis C.S., Porter E., Matthews D., Kipar A., Tasker S., Helps C.R., Siddell S.G. Genotyping Coronaviruses Associated with Feline Infectious Peritonitis. J. Gen. Virol. 2015;96:1358–1368. doi: 10.1099/vir.0.000084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000084</ArticleId><ArticleId IdType="pmc">PMC4635486</ArticleId><ArticleId IdType="pubmed">25667330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaimes J.A., Whittaker G.R. Feline Coronavirus: Insights into Viral Pathogenesis Based on the Spike Protein Structure and Function. Virology. 2018;517:108–121. doi: 10.1016/j.virol.2017.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.12.027</ArticleId><ArticleId IdType="pmc">PMC7112122</ArticleId><ArticleId IdType="pubmed">29329682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohdatsu T., Okada S., Koyama H. Characterization of Monoclonal Antibodies against Feline Infectious Peritonitis Virus Type II and Antigenic Relationship between Feline, Porcine, and Canine Coronaviruses. Arch. Virol. 1991;117:85–95. doi: 10.1007/BF01310494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01310494</ArticleId><ArticleId IdType="pmc">PMC7086586</ArticleId><ArticleId IdType="pubmed">1706593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen N.C., Black J.W., Boyle J.F., Evermann J.F., McKeirnan A.J., Ott R.L. Pathogenic Differences between Various Feline Coronavirus Isolates. Adv. Exp. Med. Biol. 1984;173:365–380.</Citation><ArticleIdList><ArticleId IdType="pubmed">6331125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen N.C., Allen C.E., Lyons L.A. Pathogenesis of Feline Enteric Coronavirus Infection. J. Feline Med. Surg. 2008;10:529–541. doi: 10.1016/j.jfms.2008.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfms.2008.02.006</ArticleId><ArticleId IdType="pmc">PMC7130060</ArticleId><ArticleId IdType="pubmed">18538604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipar A., Meli M.L., Baptiste K.E., Bowker L.J., Lutz H. Sites of Feline Coronavirus Persistence in Healthy Cats. J. Gen. Virol. 2010;91:1698–1707. doi: 10.1099/vir.0.020214-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.020214-0</ArticleId><ArticleId IdType="pubmed">20237226</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel L., Van Der Lubben M., Te Lintelo E.G., Bekker C.P.J., Geerts T., Schuijff L.S., Grinwis G.C.M., Egberink H.F., Rottier P.J.M. Pathogenic Characteristics of Persistent Feline Enteric Coronavirus Infection in Cats. Vet. Res. 2010;41:71. doi: 10.1051/vetres/2010043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1051/vetres/2010043</ArticleId><ArticleId IdType="pmc">PMC2939696</ArticleId><ArticleId IdType="pubmed">20663472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen N.C. An Update on Feline Infectious Peritonitis: Virology and Immunopathogenesis. Vet. J. 2014;201:123–132. doi: 10.1016/j.tvjl.2014.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2014.04.017</ArticleId><ArticleId IdType="pmc">PMC7110662</ArticleId><ArticleId IdType="pubmed">24837550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen N.C. An Update on Feline Infectious Peritonitis: Diagnostics and Therapeutics. Vet. J. 2014;201:133–141. doi: 10.1016/j.tvjl.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2014.04.016</ArticleId><ArticleId IdType="pmc">PMC7110619</ArticleId><ArticleId IdType="pubmed">24857253</ArticleId></ArticleIdList></Reference><Reference><Citation>Licitra B.N., Millet J.K., Regan A.D., Hamilton B.S., Rinaldi V.D., Duhamel G.E., Whittaker G.R. Mutation in Spike Protein Cleavage Site and Pathogenesis of Feline Coronavirus. Emerg. Infect. Dis. 2013;19:1066–1073. doi: 10.3201/eid1907.121094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1907.121094</ArticleId><ArticleId IdType="pmc">PMC3713968</ArticleId><ArticleId IdType="pubmed">23763835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.W., Egberink H.F., Halpin R., Spiro D.J., Rottie P.J.M. Spike Protein Fusion Peptide and Feline Coronavirus Virulence. Emerg. Infect. Dis. 2012;18:1089–1095. doi: 10.3201/eid1807.120143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1807.120143</ArticleId><ArticleId IdType="pmc">PMC3376813</ArticleId><ArticleId IdType="pubmed">22709821</ArticleId></ArticleIdList></Reference><Reference><Citation>Meli M.L., Spiri A.M., Zwicklbauer K., Krentz D., Felten S., Bergmann M., Dorsch R., Matiasek K., Alberer M., Kolberg L., et al. Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524. Viruses. 2022;14:1069. doi: 10.3390/v14051069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051069</ArticleId><ArticleId IdType="pmc">PMC9147249</ArticleId><ArticleId IdType="pubmed">35632813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jähne S., Felten S., Bergmann M., Erber K., Matiasek K., Meli M.L., Hofmann-Lehmann R., Hartmann K. Detection of Feline Coronavirus Variants in Cats without Feline Infectious Peritonitis. Viruses. 2022;14:1671. doi: 10.3390/v14081671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081671</ArticleId><ArticleId IdType="pmc">PMC9412601</ArticleId><ArticleId IdType="pubmed">36016293</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy B.G., Perron M., Murakami E., Bauer K., Park Y., Eckstrand C., Liepnieks M., Pedersen N.C. The Nucleoside Analog GS-441524 Strongly Inhibits Feline Infectious Peritonitis (FIP) Virus in Tissue Culture and Experimental Cat Infection Studies. Vet. Microbiol. 2018;219:226–233. doi: 10.1016/j.vetmic.2018.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2018.04.026</ArticleId><ArticleId IdType="pmc">PMC7117434</ArticleId><ArticleId IdType="pubmed">29778200</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen N.C., Perron M., Bannasch M., Montgomery E., Murakami E., Liepnieks M., Liu H. Efficacy and Safety of the Nucleoside Analog GS-441524 for Treatment of Cats with Naturally Occurring Feline Infectious Peritonitis. J. Feline Med. Surg. 2019;21:271–281. doi: 10.1177/1098612X19825701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1098612X19825701</ArticleId><ArticleId IdType="pmc">PMC6435921</ArticleId><ArticleId IdType="pubmed">30755068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Li T., Wang C., Liu X., Ouyang H., Ji W., Liu J., Liao X., Li J., Hu C. A Retrospective Study of Clinical and Laboratory Features and Treatment on Cats Highly Suspected of Feline Infectious Peritonitis in Wuhan, China. Sci. Rep. 2021;11:5208. doi: 10.1038/s41598-021-84754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84754-0</ArticleId><ArticleId IdType="pmc">PMC7970852</ArticleId><ArticleId IdType="pubmed">33664426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Lovell S., Tiew K.-C., Mandadapu S.R., Alliston K.R., Battaile K.P., Groutas W.C., Chang K.-O. Broad-Spectrum Antivirals against 3C or 3C-like Proteases of Picornaviruses, Noroviruses, and Coronaviruses. J. Virol. 2012;86:11754–11762. doi: 10.1128/JVI.01348-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01348-12</ArticleId><ArticleId IdType="pmc">PMC3486288</ArticleId><ArticleId IdType="pubmed">22915796</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M., Jacque N., Novicoff W., Li E., Negash R., Evans S.J.M. Unlicensed Molnupiravir Is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis. Pathogens. 2022;11:1209. doi: 10.3390/pathogens11101209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11101209</ArticleId><ArticleId IdType="pmc">PMC9612227</ArticleId><ArticleId IdType="pubmed">36297266</ArticleId></ArticleIdList></Reference><Reference><Citation>Thayer V., Gogolski S., Felten S., Hartmann K., Kennedy M., Olah G.A. 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines. J. Feline Med. Surg. 2022;24:905–933. doi: 10.1177/1098612X221118761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1098612X221118761</ArticleId><ArticleId IdType="pmc">PMC10812230</ArticleId><ArticleId IdType="pubmed">36002137</ArticleId></ArticleIdList></Reference><Reference><Citation>Takano T., Satoh K., Doki T. Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection. Front. Vet. Sci. 2021;8:647189. doi: 10.3389/fvets.2021.647189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2021.647189</ArticleId><ArticleId IdType="pmc">PMC7903937</ArticleId><ArticleId IdType="pubmed">33644160</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarnecki O., Grimm B. New Insights in the Topology of the Biosynthesis of 5-Aminolevulinic Acid. Plant Signal Behav. 2013;8:e23124. doi: 10.4161/psb.23124.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/psb.23124</ArticleId><ArticleId IdType="pmc">PMC3657009</ArticleId><ArticleId IdType="pubmed">23299429</ArticleId></ArticleIdList></Reference><Reference><Citation>Belot A., Puy H., Hamza I., Bonkovsky H.L. Update on Heme Biosynthesis, Tissue-Specific Regulation, Heme Transport, Relation to Iron Metabolism and Cellular Energy. Liver Int. 2024;44:2235–2250. doi: 10.1111/liv.15965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.15965</ArticleId><ArticleId IdType="pubmed">38888238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose S., Isoda N., Huynh L.T., Kim T., Yoshimoto K., Tanaka T., Inui K., Hiono T., Sakoda Y. Antiviral Effects of 5-Aminolevulinic Acid Phosphate against Classical Swine Fever Virus: In Vitro and In Vivo Evaluation. Pathogens. 2022;11:164. doi: 10.3390/pathogens11020164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020164</ArticleId><ArticleId IdType="pmc">PMC8877771</ArticleId><ArticleId IdType="pubmed">35215109</ArticleId></ArticleIdList></Reference><Reference><Citation>Smetana Z., Malik Z., Orenstein A., Mendelson E., Ben-Hur E. Treatment of Viral Infections With 5-Aminolevulinic Acid and Light. Lasers Surg. Med. 1997;21:351–358. doi: 10.1002/(SICI)1096-9101(1997)21:4&lt;351::AID-LSM6&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9101(1997)21:4&lt;351::AID-LSM6&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">9328982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai Y., Ngwe Tun M.M., Kurosaki Y., Sakura T., Inaoka D.K., Fujine K., Kita K., Morita K., Yasuda J. 5-Amino Levulinic Acid Inhibits SARS-CoV-2 Infection in Vitro. Biochem. Biophys. Res. Commun. 2021;545:203–207. doi: 10.1016/j.bbrc.2021.01.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.01.091</ArticleId><ArticleId IdType="pmc">PMC7846235</ArticleId><ArticleId IdType="pubmed">33571909</ArticleId></ArticleIdList></Reference><Reference><Citation>Doki T., Toda M., Hasegawa N., Hohdatsu T., Takano T. Therapeutic Effect of an Anti-Human-TNF-Alpha Antibody and Itraconazole on Feline Infectious Peritonitis. Arch. Virol. 2020;165:1197–1206. doi: 10.1007/s00705-020-04605-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04605-7</ArticleId><ArticleId IdType="pmc">PMC7110289</ArticleId><ArticleId IdType="pubmed">32236683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut M., Leutenegger C.M., Huder J.B., Pedersen N.C., Lutz H. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J. Virol. Methods. 1999;77:37–46. doi: 10.1016/S0166-0934(98)00129-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-0934(98)00129-3</ArticleId><ArticleId IdType="pmc">PMC7185542</ArticleId><ArticleId IdType="pubmed">10029323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Pan X., Chen D., Xie X., Wu Y., Shang W., Jiang X., Sun Y., Fan S., He J. Broad-Spectrum Antivirals of Protoporphyrins Inhibit the Entry of Highly Pathogenic Emerging Viruses. Bioorg Chem. 2021;107:104619. doi: 10.1016/j.bioorg.2020.104619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2020.104619</ArticleId><ArticleId IdType="pmc">PMC7784547</ArticleId><ArticleId IdType="pubmed">33450541</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K., Fujiwara T., Ota U., Hatta S., Ichikawa S., Kobayashi M., Okitsu Y., Fukuhara N., Onishi Y., Ishizuka M., et al. Dynamics of Absorption, Metabolism, and Excretion of 5-Aminolevulinic Acid in Human Intestinal Caco-2 Cells. Biochem. Biophys. Rep. 2017;11:105–111. doi: 10.1016/j.bbrep.2017.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2017.07.006</ArticleId><ArticleId IdType="pmc">PMC5614713</ArticleId><ArticleId IdType="pubmed">28955775</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Konduru K., Solovena V., Zhou Z.-H., Kumari N., Takeda K., Nekhai S., Bavari S., Kaplan G.G., Yamada K.M., et al. Therapeutic Potential of the Heme Oxygenase-1 Inducer Hemin against Ebola Virus Infection. Curr. Trends Immunol. 2016;17:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5267496</ArticleId><ArticleId IdType="pubmed">28133423</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., Zhang A., Zhang C., Ni H., Gao J., Wang C., Zhao Q., Wang X., Wang X., Ma C., et al. Heme Oxygenase-1 Acts as an Antiviral Factor for Porcine Reproductive and Respiratory Syndrome Virus Infection and over-Expression Inhibits Virus Replication in Vitro. Antivir. Res. 2014;110:60–69. doi: 10.1016/j.antiviral.2014.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.07.011</ArticleId><ArticleId IdType="pubmed">25086213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Wang X., Zhang K., Gao K., Song M., Liu Q. The Spectroscopy Analyses of PpIX by Ultrasound Irradiation and Its Sonotoxicity in Vitro. Ultrasonics. 2013;53:935–942. doi: 10.1016/j.ultras.2012.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ultras.2012.10.019</ArticleId><ArticleId IdType="pubmed">23415145</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamurthy P., Schuetz J.D. The Role of ABCG2 and ABCB6 in Porphyrin Metabolism and Cell Survival. Curr. Pharm. Biotechnol. 2011;12:647–655. doi: 10.2174/138920111795163995.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920111795163995</ArticleId><ArticleId IdType="pubmed">21118089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L.L., Zhang P., Wang H.Q., Li Y.F., Hu J., Jiang J.D., Li Y.H. Heme Oxygenase-1 Agonist CoPP Suppresses Influenza Virus Replication through IRF3-Mediated Generation of IFN-α/β. Virology. 2019;528:80–88. doi: 10.1016/j.virol.2018.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.11.016</ArticleId><ArticleId IdType="pubmed">30580124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Ahn H.S., Go H.J., Kim D.Y., Kim J.H., Lee J.B., Park S.Y., Song C.S., Lee S.W., Do Ha S., et al. Hemin as a Novel Candidate for Treating COVID-19 via Heme Oxygenase-1 Induction. Sci. Rep. 2021;11:21462. doi: 10.1038/s41598-021-01054-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01054-3</ArticleId><ArticleId IdType="pmc">PMC8563742</ArticleId><ArticleId IdType="pubmed">34728736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>